Greater than 90%.
HBV-X Recombinant produced in E. coli is a single polypeptide chain containing 165 amino acids (2-154) and having a molecular mass of 17.8 kDa.
HBV-X is fused to a 12 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
The Hepatitis B virus X protein (HBx), with a molecular weight of 17 kDa, functions as a transcriptional coactivator and plays a crucial role in regulating genes associated with inflammation and cell survival. It exerts its regulatory effects on various transcription factors, including NF-kappaB, and is heavily implicated in the development of liver cancer (hepatocarcinogenesis). Notably, HBx facilitates the binding of cAMP response element binding protein (CREB) to its corresponding response element. Furthermore, HBx stabilizes the cellular coactivator ASC-2 via direct protein-protein interaction, thereby influencing the regulation of genes actively transcribed in liver cancer cells. It also activates both the JNK and MAPK signaling pathways, contributing to the mobilization of cytosolic Ca2+. The interaction between HBx and the general transcription factor TFIIB represents another mechanism underlying its transcriptional transactivation activity. Importantly, HBx has been shown to downregulate the expression of PTEN, a known tumor suppressor gene and a negative regulator of the phosphatidylinositol 3'-kinase/AKT pathway. The development of hepatocellular carcinoma (HCC) is often linked to hepatitis B virus (HBV) infection, and HBx, in particular, plays a pivotal role in HBV-related HCC. The persistent presence of HBx is critical to the pathogenesis of early-stage HCC, and its expression in the liver during chronic HBV infection may serve as a valuable prognostic marker for HCC development.
Recombinant HBV-X, produced in E. coli, is a single polypeptide chain comprising 165 amino acids (residues 2-154) with a molecular weight of 17.8 kDa. It is fused to a 12 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Exceeds 90%.
The protein is filtered through a 0.4 μm filter and subsequently lyophilized from a solution containing 0.5 mg/ml protein in 50 mM acetate buffer (pH 4) and 5% trehalose.
MRGSHHHHHH GSAARVCCQL DPARDVLCLR PVGAESRGRP VSGPFGTLPS PSSSAVPADH GAHLSLRGLP VCAFSSAGPC ALRFTSARRM ETTVNAHQVL PKVLHKRTLG LSAMSTTDLE AYFKDCLFKD WEELGEEIRL KVFVLGGCRH KLVCSPAPCN FFTSA.
Hepatitis B virus (HBV) is a significant global health concern, affecting approximately 240 million people worldwide. Chronic HBV infection can lead to severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HBV X protein (HBx) is a multifunctional regulatory protein that plays a crucial role in the viral life cycle and pathogenesis. Recombinant HBx proteins, especially those tagged with histidine (His tag), are widely used in research to study the protein’s structure, function, and interactions.
The HBx protein is a small, non-structural protein encoded by the HBV genome. It is involved in various cellular processes, including transcriptional regulation, signal transduction, and apoptosis. HBx is essential for viral replication and has been implicated in the development of HBV-related liver diseases. Due to its critical role, HBx is a target for therapeutic interventions and vaccine development .
Recombinant HBx proteins are produced using genetic engineering techniques. The gene encoding HBx is cloned into an expression vector, which is then introduced into a host organism, such as Escherichia coli. The host organism expresses the HBx protein, which can be purified and used for various research applications. The His tag is a short sequence of histidine residues added to the protein’s N- or C-terminus to facilitate purification using affinity chromatography .
Recombinant HBx proteins are used in a wide range of research applications, including: